Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.

Quality of Life Clinical Trial

— REVOR  

Official title:

Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric: Study of Superiority, Randomized, Controlled, Prospective, Single Blind

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03393299
• Other study ID #: RC-P0059
• Status: Completed
• Phase: N/A
• Start date: January 16, 2018
• Est. completion date: October 30, 2018

Study information

• Verified date: August 2020
• Source: Lille Catholic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: October 30, 2018
• Est. primary completion date: July 17, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• Patient with more than 75 years old

• Hospitalized in geriatrics short-stay

• Patient with a written informed consent

• Patient with a social security scheme

Exclusion Criteria:

• Severe dementia

• Not able to respond to SF-12

• Disease at final stage

• Patient under legal protection (maintenance of justice, tutelage, legal guardianship)

Related Conditions & MeSH terms

• Drug Use
• Quality of Life

Intervention

Procedure:
• STOPP/START criteria
software which helps to do the drug reconciliation

Locations

Country	Name	City	State
France	Hôpital La Porte Verte	Versailles

Sponsors (1)

Lead Sponsor	Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	SF-12 Quality of life scale	The evolution of the hospitalised elderly people's quality of life at 2 months will be measured by the SF-12 scale.	at inclusion and at 2 months
Secondary	Number of falls	The number of falls during the two months following the inclusion will be collected for each patient.	at 2 months
Secondary	Proportion of patients rehospitalized	The proportion of patients that have been rehospitalized (unscheduled hospitalization) during the two months following inclusion will be measured.	at 2 months
Secondary	Mortality	The mortality during the two months following inclusion will be measured.	at 2 months